| Literature DB >> 23237036 |
Torello M Lotti1, Jana Hercogová, Robert A Schwartz, Dionigi Tsampau, Igor Korobko, Aldona Pietrzak, Natasa Teovska Mitrevska, Yan Valle, Gionata Buggiani.
Abstract
Vitiligo is a manageable disease. However, current vitiligo treatments can be considered suboptimal as they do not guarantee high efficacy and cannot be standardized for most patients. Recently, combination therapies have been introduced in order to obtain better results and reduce risks in the management of the disease. Novel efficacious products are hereunder discussed to improve the therapeutic options for vitiligo patients.Entities:
Mesh：
Substances：
Year: 2012 PMID： 23237036 DOI： 10.1111/dth.12011
Source DB: PubMed Journal: Dermatol Ther ISSN： 1396-0296 Impact factor: 2.851